UBS/CALL/ABBOTT LABORATORIES/135/0.1/20.12.24 Stock

Warrant

CH1267668338

Market Closed - Deutsche Boerse AG 13:40:36 2024-06-28 EDT
0.007 EUR -30.00% Intraday chart for UBS/CALL/ABBOTT LABORATORIES/135/0.1/20.12.24
Current month+600.00%
1 month-73.08%
Date Price Change
24-06-28 0.007 -30.00%
24-06-27 0.01 -23.08%
24-06-26 0.013 -13.33%
24-06-25 0.015 -61.54%
24-06-24 0.039 -9.30%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 01:40 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer UBS
WKN UL37KT
ISINCH1267668338
Date issued 2023-05-04
Strike 135 $
Maturity 2024-12-20 (173 Days)
Parity 10 : 1
Emission price 0.54
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.6
Lowest since issue 0.001
Delta0.06x
Omega 16.08
Premium30.3x
Gearing262.2x
Moneyness 0.7697
Difference Strike 31.09 $
Difference Strike %+23.03%
Spread 0.06
Spread %89.55%
Intrinsic value 0.000000

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.9 USD
Average target price
125.2 USD
Spread / Average Target
+20.45%
Consensus